plasminogen activator inhibitor-1 (PAI-1)
openaire +2 more sources
Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1. [PDF]
Ibrahim AA +9 more
europepmc +1 more source
Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis. [PDF]
Barrett CD +15 more
europepmc +1 more source
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases. [PDF]
Jójárt B +12 more
europepmc +1 more source
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update. [PDF]
Maghsudlu M +3 more
europepmc +1 more source
Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll-like receptor 2 and plasminogen activator inhibitor-1. [PDF]
Kim HY +6 more
europepmc +1 more source
Plasminogen activator inhibitor-1 in cancer research.
[Despite as a major inhibitor of urokinase (uPA), paradoxically,] Plasminogen activator inhibitor-1 (PAI-1) has been validated to be highly expressed in various types of tumor biopsy tissues or plasma compared with controls based on huge clinical data bases analysis, more importantly, PAI-1 alone or in conjunction with uPA have been identified as ...
Sijing Li +5 more
semanticscholar +3 more sources

